“Receiving orphan drug designation for TPST-1495, our second clinical program, is a significant milestone in our mission to bring innovative therapies to patients with unmet medical need ...

Tempest Therapeutics, Inc. has announced that the FDA has granted Orphan Drug Designation to its dual receptor inhibitor TPST-1495 for treating Familial Adenomatous Polyposis (FAP), a rare genetic ...

Tempest Therapeutics (TPST) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation, ODD, to TPST-1495, the company’s novel dual receptor inhibitor of ...

CAMARILLO, Calif., October 31, 2024--Salem Media Group, Inc. (OTCQX: SALM) and the Breitbart News Network announced today the launch of "The Alex Marlow Show – A Breitbart News Podcast ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. Full text is unavailable for this digitized archive article. Subscribers may view the full text of this article in ...

"Receiving orphan drug designation for TPST-1495, our second clinical program, is a significant milestone in our mission to bring innovative therapies to patients with unmet medical need,” said ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist ...

Donald Trump on Thursday called on Vladimir Putin to halt attacks on Ukraine, in a rare rebuke of the Russian leader after Moscow fired a barrage of missiles and drones at Kyiv, killing at least ...

"Receiving orphan drug designation for TPST-1495, our second clinical program, is a significant milestone in our mission to bring innovative therapies to patients with unmet medical need," said ...

A man who was killed in an Algiers shooting over the weekend was identified by the Orleans Parish Coroner's Office Wednesday as 51-year-old Andrew Beverly. Beverly was shot in the head at around ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...